光动力疗法治疗鼻部基底细胞癌及其皮肤镜特征

2018-12-24 周萌 刘保国 张晶 临床皮肤科杂志

患者男,68 岁。因鼻背部丘疹 2 年伴糜烂 3 个月, 于 2016 年 10 月 20 日就诊于我院皮肤科。患者 2 年前 无明显诱因鼻背部出现一黄豆大红色丘疹,无不适。3 个月前皮损表面出现破溃及糜烂,伴瘙痒,皮损难以愈 合。患者既往体健,否认手术及外伤史,否认食物及药 物过敏史。家族中无类似疾病患者。 体格检查:生命体征正常,咽后壁无充血,双侧扁 桃体无肿大,各系统检查均正常。

1 病历摘要

患者男,68 岁。因鼻背部丘疹 2 年伴糜烂 3 个月, 于 2016 年 10 月 20 日就诊于我院皮肤科。患者 2 年前 无明显诱因鼻背部出现一黄豆大红色丘疹,无不适。3 个月前皮损表面出现破溃及糜烂,伴瘙痒,皮损难以愈 合。患者既往体健,否认手术及外伤史,否认食物及药 物过敏史。家族中无类似疾病患者。 体格检查:生命体征正常,咽后壁无充血,双侧扁 桃体无肿大,各系统检查均正常。

皮肤科检查: 鼻背部 一 1.0 cm×1.0 cm 斑块,表面糜烂及结痂,皮损及周边 可见毛细血管扩张(图 1A)。 实验室检查:血、尿、粪常规,肝、肾功能,胸部 X 射线检查和心电图均正常。



皮肤镜检查:皮损中央可见溃疡及结痂,散在树枝 状血管、蓝灰色色素小球及枫叶样区域,缺乏色素网 (图 2A)。患者及家属拒绝行皮损组织病理检查。 诊断:基底细胞癌(BCC)。

治疗:予光动力疗法(PDT)治疗。生理盐水湿敷皮 损 30 min,待痂皮充分软化后,予无菌棉棒清除痂皮及 清洁皮损。新鲜配制 20% 5-氨基酮戊酸(ALA)涂于皮 损处,塑料薄膜封包避光敷药 4 h。PDT 治疗仪治疗波 长(633±3)nm,输出功率 80~100 mW/cm2,照射总能量 100~120 J/cm2,间隔时间 7~10 d。PDT 治疗 2 次后皮损 处糜烂愈合,部分结痂脱落(图 1B);皮肤镜下观察皮 损处溃疡消失,中央可见大量树枝样血管,边缘处可见 大量蓝灰色的色素小球及枫叶样区域(图 2B)。治疗 4 次后痂壳完全脱落(图 1C);皮肤镜下皮损处仍可见少 许树枝样血管,边缘可见少许蓝灰色小球(图 2C)。予 火针预处理皮损后再给予第 5 次 PDT 治疗。仅第 1 次 治疗时患者诉疼痛较剧烈,予冷风喷吹皮损后,患者诉 疼痛明显减轻。治疗结束后无不良反应发生。治疗 1 个月后皮损完全消退,随访 6 个月,病情无复发。

2 讨 论

BCC 是一种常见的皮肤恶性肿瘤,主要由间质依 赖性多潜能基底样细胞组成,具有一定的侵袭性和破 坏性[1]。皮肤镜可直观地观察表皮和表皮下部肉眼无 法识别的形态学特征[2],与组织病理检查相比,易被患 者接受。皮肤镜除了用于协助诊断色素性皮肤肿瘤 外,在非色素性皮肤肿瘤如 BCC 的诊断方面也得到 广泛地应用[3-6]。皮肤镜诊断 BCC 的指征主要为 1 个 阴性标准:不含色素网; 6 个阳性特点:①大的蓝灰色 卵圆形巢;②多发的蓝灰色小球;③枫叶样区域;④轮 辐状区域; ⑤溃疡;⑥树枝状毛细血管扩张。满足 1 个 阴性标准, 6 个阳性特点至少具备其一即可诊断为 BCC[3]。Marghoob 等[4]报告依靠肉眼诊断 BCC 的正确 率为 60%~70%。李琨等[5]研究证明,皮肤镜诊断色素 性 BCC 的正确率为 91.67%。皮肤镜诊断 BCC 与组织 病理诊断的符合率为 94.81%[6]。本例患者具有 BCC 的 典型临床特征,皮肤镜非偏振光下可见溃疡、树枝状 血管、蓝灰色的色素小球及枫叶样区域,并缺乏色素 网。本例患者经过 4 次 PDT 治疗后临床上可见皮损变 平,颜色明显变淡,但皮肤镜下部分皮损仍可见树枝 状结构、蓝灰色小球及枫叶状区域,考虑可能与此处 皮损浸润较深有关。 PDT 指光敏剂进入体内受到适当波长光的激发 产生一系列光化学毒性效应,从而导致病变组织损伤 的一种治疗方法。ALA-PDT 治疗皮肤肿瘤具有疗效 好、选择性高、创伤小、耐受性高、美容效果好及可重 复治疗等优点。ALA-PDT 对于浅表型 BCC 治愈率为 79%~100%,结节型和溃疡型治愈率为 10%~50%,硬 化型效果较差,但对于特殊部位皮损、身体耐受性差、 美容要求高、皮损面积大或多发而难于手术的患者, ALA-PDT 是一种很好的替代治疗手段[1]。Cosgarea 等[7] 研究发现 ALA-PDT 治疗浅表型 BCC 治愈率为 95.84%,复发率为 4.16%;手术疗法治愈率为 95.65%,复发率为 4.34%(P>0.05),但 ALA-PDT 的美容效果 (100.00%)则明显高于手术疗法(88.86%)(P<0.05)。葛 新红等[8]报告采用 ALA-PDT 治疗浅表型 BCC 治愈率 高,且美容效果佳,无不良反应。本例患者皮损位于鼻 背部,糜烂较明显且面积较大,不易进行外科手术治 疗。前期清除皮损表面痂皮,予 ALA-PDT 治疗 4 次 后,患者皮损症状明显改善但未完全消退。根据皮肤镜 表现对皮损残留部位予火针预处理,使药物更好的渗 透至皮损的基底部,达到了满意的治疗效果。

本文提示对于头、面部或特殊部位的 BCC 临床行 皮损组织病理检查可能会影响患者美容,皮损难以愈 合,患者的依从性差。通过无创的皮肤镜检查,可以减 少盲目活检,为疾病的早期诊断提供充分的诊断依据。 采用火针结合 PDT 治疗 BCC,将 ALA 更好地渗透至 皮损基底部,对浸润较深的皮损可达到较为理想的治 疗效果,但由于本例患者随访时间较短,故远期疗效仍 需临床上进一步验证。

参考文献略。

原始出处:

周萌,刘保国,张晶,苗国英. 光动力疗法治疗鼻部基底细胞癌及其皮肤镜特征[J]. 临床皮肤科杂志,2018,47(11):747-748.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1705272, encodeId=64b31e052728b, content=<a href='/topic/show?id=6ab4e212750' target=_blank style='color:#2F92EE;'>#皮肤镜特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72127, encryptionId=6ab4e212750, topicName=皮肤镜特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcb330960212, createdName=周虎, createdTime=Sun May 05 21:19:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994082, encodeId=83dd1994082c7, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Wed May 29 15:19:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978785, encodeId=ef0f19e8785bc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Sep 06 17:19:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486650, encodeId=0d3b148665045, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546315, encodeId=481e15463154b, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1705272, encodeId=64b31e052728b, content=<a href='/topic/show?id=6ab4e212750' target=_blank style='color:#2F92EE;'>#皮肤镜特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72127, encryptionId=6ab4e212750, topicName=皮肤镜特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcb330960212, createdName=周虎, createdTime=Sun May 05 21:19:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994082, encodeId=83dd1994082c7, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Wed May 29 15:19:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978785, encodeId=ef0f19e8785bc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Sep 06 17:19:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486650, encodeId=0d3b148665045, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546315, encodeId=481e15463154b, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1705272, encodeId=64b31e052728b, content=<a href='/topic/show?id=6ab4e212750' target=_blank style='color:#2F92EE;'>#皮肤镜特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72127, encryptionId=6ab4e212750, topicName=皮肤镜特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcb330960212, createdName=周虎, createdTime=Sun May 05 21:19:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994082, encodeId=83dd1994082c7, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Wed May 29 15:19:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978785, encodeId=ef0f19e8785bc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Sep 06 17:19:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486650, encodeId=0d3b148665045, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546315, encodeId=481e15463154b, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1705272, encodeId=64b31e052728b, content=<a href='/topic/show?id=6ab4e212750' target=_blank style='color:#2F92EE;'>#皮肤镜特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72127, encryptionId=6ab4e212750, topicName=皮肤镜特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcb330960212, createdName=周虎, createdTime=Sun May 05 21:19:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994082, encodeId=83dd1994082c7, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Wed May 29 15:19:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978785, encodeId=ef0f19e8785bc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Sep 06 17:19:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486650, encodeId=0d3b148665045, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546315, encodeId=481e15463154b, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1705272, encodeId=64b31e052728b, content=<a href='/topic/show?id=6ab4e212750' target=_blank style='color:#2F92EE;'>#皮肤镜特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72127, encryptionId=6ab4e212750, topicName=皮肤镜特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcb330960212, createdName=周虎, createdTime=Sun May 05 21:19:00 CST 2019, time=2019-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994082, encodeId=83dd1994082c7, content=<a href='/topic/show?id=a6c4420601d' target=_blank style='color:#2F92EE;'>#基底细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42060, encryptionId=a6c4420601d, topicName=基底细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Wed May 29 15:19:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978785, encodeId=ef0f19e8785bc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Fri Sep 06 17:19:00 CST 2019, time=2019-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486650, encodeId=0d3b148665045, content=<a href='/topic/show?id=860ae21262f' target=_blank style='color:#2F92EE;'>#皮肤镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72126, encryptionId=860ae21262f, topicName=皮肤镜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f408195718, createdName=lvliquan, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546315, encodeId=481e15463154b, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Wed Dec 26 12:19:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]

相关资讯

Clin Oral Investig:常规根管治疗联合光动力疗法可更好的促进根尖周愈合

本项随机对照试验旨在光动力疗法(PDT)对临床成功(根尖周愈合)和原发性牙髓感染微生物的有效性。将伴有下颌磨牙根尖周炎的32名患者随机分为对照组(化学机械清创[CMD];n = 16)和PDT(CMD + PDT;n = 16)两组。两组中的所有牙齿在最后的封闭之前用氢氧化钙根管内内给药7天。第3个月和6个月随访进行X光片检查。按照根尖指数(PAI)评估根尖周愈合。基线时期,CMD之后联合或不联合

CLIN CANCER RES:血管靶向光动力疗法可以增强PD-1/PD-L1通路阻滞抗肿瘤免疫反应

PD-1/PD-L1通路抑制可以有效治疗晚期肾细胞癌。但是其结果变化很大,可能取决于宿主因素,包括肿瘤微环境。使用光敏剂WST11的血管靶向光动力疗法(VTP)可以诱导局部免疫反应。CLIN CANCER RES近期发表了一篇文章,研究光动力疗法是否可以增强PD-1通路抑制的局部和系统抗肿瘤反应。

J Endod:光动力疗法对纤维桩粘接表面的影响

这篇研究的目的是为了评估光动力疗法(PDT)对使用常规树脂水门汀(Relyx ARC; 3M ESPE, St Paul, MN)或自粘接系统(Relyx U200, 3M ESPE)粘接玻璃纤维桩时的粘接强度和牙本质渗透性的影响。

Clin Oral Invest:光动力疗法治疗原发性牙髓感染的临床和微生物疗效

试验评估了光动力治疗(PDT)对临床成功(根尖周愈合)和原发性牙髓感染的微生物群的作用。

J Periodontal Res: :光动力疗法与阿仑膦酸钠对牙周炎大鼠牙槽骨吸收的协同作用

已经证明,光动力疗法(PDT)和抗吸收药物,如阿仑膦酸钠(ALN)可以减少牙槽骨吸收。本研究旨在证明PDT和ALN联合应用对牙周炎大鼠骨吸收可能的协同作用。

Clin Oral Investig:光动力疗法对原发性牙髓感染的临床和微生物效果的影响:一项6个月的临床随机试验

这项短期随机对照试验的目的是为了评估光动力疗法(PDT)对原发性牙髓感染的临床疗效成功率(根尖愈合)和菌群微生物的影响。